Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06305481 · ClinicalTrials.gov registry record · NA
Glaucoma Evaluation With the P200TE
A NA study, sponsored by Optos.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT06305481: Completed NA study, sponsored by Optos.
NCT06305481 is a NA study that has completed, run by Optos. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06305481, a NA study, has completed, sponsored by Optos.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
Images captured on the P200TE device on glaucoma patients
Interventions
- DEVICE P200TE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2024-02-13 |
| Est. Completion | 2024-10-23 |
| Phase | NA |
What the finished NCT06305481 record still lists
NCT06305481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which P200TE is the first listed.
NCT06305481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06305481 about?
NCT06305481 is a clinical study titled "Glaucoma Evaluation With the P200TE". Images captured on the P200TE device on glaucoma patients
What is the current status of trial NCT06305481?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2024-02-13. Estimated completion is 2024-10-23.
What interventions are being tested in trial NCT06305481?
The interventions under investigation include: P200TE (DEVICE).
Who is sponsoring clinical trial NCT06305481?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06305481's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI